{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:50:52Z","timestamp":1787313052062,"version":"build-2736575974"},"reference-count":25,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T00:00:00Z","timestamp":1675123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>The aim of this study was to evaluate the effectiveness and safety of a yellow subthreshold laser (STL) for the treatment of chronic central serous chorioretinopathy delivered in a fovea-sparing pattern and to analyze the post-laser changes in the choroidal structure by Swept-Source Optical Coherence Tomography. This study was a prospective case series of 43 eyes corresponding to 37 patients. Data were recorded at 6, 12 and 24 weeks after the STL treatment. The best-corrected visual acuity improved in 93% of the patients and remained stable in 7%. The subretinal fluid was completely reabsorbed in 27.9%, 32.6% and 69.8% of the patients at 6, 12 and 24 weeks, respectively. There were reductions in the choroidal thickness of 13.1% and 25.3% at 12 and 24 weeks, which corresponded to reductions of 17.5% and 45.9% in the choriocapillaris and Sattler layer and reductions of 12.2% and 21.2% in the Haller layer at 12 and 24 weeks, respectively (p &lt; 0.05). This might account for the effect of the laser on the inner choroidal vasculature, the dysregulation of which is believed to be at the core of central serous chorioretinopathy. No laser-related complications were detected. Overall, the fovea-sparing STL was safe and effective in this series of patients.<\/jats:p>","DOI":"10.3390\/jcm12031127","type":"journal-article","created":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T01:36:59Z","timestamp":1675215419000},"page":"1127","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser"],"prefix":"10.3390","volume":"12","author":[{"given":"Beatriz","family":"Torrellas","sequence":"first","affiliation":[{"name":"Ophtalmology Department, Joan XXIII University Hospital, 43007 Tarragona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Sanitaria Pere Virgili (IISPV), Rovira & Virgili University, 43204 Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Filloy","sequence":"additional","affiliation":[{"name":"Ophtalmology Department, Joan XXIII University Hospital, 43007 Tarragona, Spain"},{"name":"Institut d\u2019Investigaci\u00f3 Sanitaria Pere Virgili (IISPV), Rovira & Virgili University, 43204 Reus, Spain"},{"name":"Cl\u00ednica Oftalmol\u00f2gica de Tarragona (COT), 43001 Tarragona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-7058","authenticated-orcid":false,"given":"Lihteh","family":"Wu","sequence":"additional","affiliation":[{"name":"Asociados de M\u00e1cula, V\u00edtreo y Retina de Costa Rica, San Jos\u00e9 10102, Costa Rica"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1772-3558","authenticated-orcid":false,"given":"Jay","family":"Chhablani","sequence":"additional","affiliation":[{"name":"UPMC Eye Center, University of Pittsburgh, Pittsburgh, PA 15213, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7061-8987","authenticated-orcid":false,"given":"Pedro","family":"Romero-Aroca","sequence":"additional","affiliation":[{"name":"Institut d\u2019Investigaci\u00f3 Sanitaria Pere Virgili (IISPV), Rovira & Virgili University, 43204 Reus, Spain"},{"name":"Ophthalmology Department, University Hospital Sant Joan de Reus, 43204 Reus, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.preteyeres.2015.05.003","article-title":"Central serous chorioretinopathy: Recent findings and new physiopathology hypothesis","volume":"48","author":"Daruich","year":"2015","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.2147\/OPTH.S220845","article-title":"Central Serous Chorioretinopathy: Pathogenesis and Management","volume":"13","author":"Semeraro","year":"2019","journal-title":"Clin. Ophthalmol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.survophthal.2012.12.001","article-title":"Optical coherence tomography: Imaging of the choroid and beyond","volume":"58","author":"Mrejen","year":"2013","journal-title":"Surv. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41433-018-0158-4","article-title":"Pachychoroid disease","volume":"33","author":"Cheung","year":"2019","journal-title":"Eye"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s12325-017-0559-y","article-title":"A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders","volume":"34","author":"Scholz","year":"2017","journal-title":"Adv. Ther."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/eye.2017.293","article-title":"Visual outcomes and anatomic changes after sub-threshold micropulse yellow laser (577-nm) treatment for chronic central serous chorioretinopathy: Long-term follow-up","volume":"32","author":"Arsan","year":"2018","journal-title":"Eye"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1038\/s41433-022-02136-w","article-title":"Subthreshold laser therapy guidelines for retinal diseases","volume":"36","author":"Chhablani","year":"2022","journal-title":"Eye"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.ophtha.2013.01.066","article-title":"Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography","volume":"120","author":"Branchini","year":"2013","journal-title":"Ophthalmology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1038\/s41433-019-0692-8","article-title":"Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy","volume":"34","author":"Sun","year":"2020","journal-title":"Eye"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/eye.2016.142","article-title":"Comparison of subthreshold micropulse laser (577 nm) treatment and half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy","volume":"30","author":"Scholz","year":"2016","journal-title":"Eye"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1097\/IAE.0000000000002764","article-title":"Changes in choriocapillaris, Sattler, and Haller layer thickness in central serous chorioretinopathy after half-fluence photodynamic therapy","volume":"40","author":"Sastre","year":"2020","journal-title":"Retina"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/humu.22551","article-title":"Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy","volume":"35","author":"Schubert","year":"2014","journal-title":"Hum. Mutat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1172\/JCI61427","article-title":"Mineralocorticoid receptor is involved in rat and human ocular chorioretinopathy","volume":"122","author":"Zhao","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1167\/tvst.10.8.9","article-title":"Peripapillary Choroidal Vascularity Outside the Macula in Patients with Central Serous Chorioretinopathy","volume":"10","author":"Kim","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Agrawal, R., Salman, M., Tan, K.A., Karampelas, M., Sim, D.A., Keane, P.A., and Pavesio, C. (2016). Choroidal Vascularity Index (CVI)-A Novel Optical Coherence Tomography Parameter for Monitoring Patients with Panuveitis?. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0146344"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e1522","DOI":"10.1111\/aos.15148","article-title":"Clinical impact of the worldwide shortage of verteporfin (Visudyne\u00ae) on ophthalmic care","volume":"100","author":"Sirks","year":"2022","journal-title":"Acta Ophthalmol."},{"key":"ref_18","unstructured":"(2023, January 14). Shortage of Visudyne (Verteporfin), European Medicine Agency. Available online: https:\/\/www.ema.europa.eu\/en\/documents\/shortage\/visudyne-verteporfin-supply-shortage_en.pdf."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.ophtha.2018.04.021","article-title":"Half-Dose Photodynamic Therapy versus High-Density Subthreshold Micropulse Laser Treatment in Patients with Chronic Central Serous Chorioretinopathy: The PLACE Trial","volume":"125","author":"Fauser","year":"2018","journal-title":"Ophthalmology"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1186\/s13063-015-0939-z","article-title":"Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): Study protocol for a randomized controlled trial","volume":"16","author":"Breukink","year":"2015","journal-title":"Trials"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1136\/bjophthalmol-2017-311291","article-title":"Yellow (577 nm) micropulse laser versus half-dose verteporfin photodynamic therapy in eyes with chronic central serous chorioretinopathy: Results of the Pan-American Collaborative Retina Study (PACORES) Group","volume":"102","author":"Roca","year":"2018","journal-title":"Br. J. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wu, Z., Wang, H., and An, J. (2021). Comparison of the efficacy and safety of subthreshold micropulse laser with photodynamic therapy for the treatment of chronic central serous chorioretinopathy: A meta-analysis. Medicine, 100.","DOI":"10.1097\/MD.0000000000025722"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/ceo.12754","article-title":"Short-pulse duration retinal lasers: A review","volume":"44","author":"Chehade","year":"2016","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Filloy, A., Chong, V., and Sol\u00e9, E. (2020). Subthreshold yellow laser for fovea-involving diabetic macular edema in a series of patients with good vision: Effectiveness and safety of a fovea-sparing technique. BMC Ophthalmol., 20.","DOI":"10.1186\/s12886-020-01536-4"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Gaw\u0119cki, M., Jaszczuk-Maciejewska, A., Jurska-Ja\u015bko, A., Kneba, M., and Grzybowski, A. (2019). Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset. J. Clin. Med., 8.","DOI":"10.3390\/jcm8091398"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/1127\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:20:16Z","timestamp":1760120416000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/12\/3\/1127"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,31]]},"references-count":25,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["jcm12031127"],"URL":"https:\/\/doi.org\/10.3390\/jcm12031127","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,31]]}}}